Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
CROSS-LINKING AGENT Epidermal growth factor receptor erbB1 cross-linking agent PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Central Nervous System Neoplasms 1 D016543 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109391